{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:30:14Z","timestamp":1790249414680,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inflammation and oxidative stress can contribute to the development and progression of heart failure. This study aimed to investigate the association between inflammatory and oxidative stress markers in dogs with congestive heart failure (CHF). Associations between the disease severity marker N-terminal pro-B-type natriuretic peptide (NT-proBNP) and markers of inflammation and oxidative stress were also determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty-seven dogs with cardiovascular diseases (dilated cardiomyopathy, DCM (16 dogs), myxomatous mitral valve disease, MMVD (21 dogs)) and ten healthy dogs were included in this prospective study. The patients were further divided into groups with (26) and without CHF (11). We found a significantly higher serum concentration of C-reactive protein (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.012), white blood cell (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001), neutrophil (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001) and monocyte counts (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001) in patients with CHF compared to control dogs. The concentration of tumor necrosis factor-alpha (TNF-\u03b1) was significantly higher in patients with CHF compared to patients without CHF (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.030). No significant difference was found in most of the measured parameters between MMVD and DCM patients, except for glutathione peroxidase\u00a0(GPX) and NT-proBNP. In patients with CHF, TNF-\u03b1 correlated positively with malondialdehyde (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.014,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.474) and negatively with GPX (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.026,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u20090.453), and interleukin-6 correlated negatively with GPX (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.046,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u20090.412). NT-proBNP correlated positively with malondialdehyde (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.011,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.493). In patients without CHF none of the inflammatory and oxidative stress markers correlated significantly. Furthermore, in the group of all cardiac patients, GPX activity significantly negatively correlated with NT-proBNP (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.050,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u20090.339) and several markers of inflammation, including TNF-\u03b1 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.010,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u20090.436), interleukin-6 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.026,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u20090.382), white blood cell (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.032,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u20090.369), neutrophil (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.027,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u20090.379) and monocyte counts (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.024,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u20090.386).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Inflammatory and oxidative stress markers are linked in canine CHF patients, but not in patients without CHF. These results suggest complex cross communication between the two biological pathways in advanced stages of CHF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12917-021-02878-x","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T09:04:18Z","timestamp":1619427858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Inflammation and its association with oxidative stress in dogs with heart failure"],"prefix":"10.1186","volume":"17","author":[{"given":"Alenka","family":"Nemec Svete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Verk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"\u010cebulj-Kadunc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janez","family":"Salobir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vida","family":"Rezar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Domanjko Petri\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"issue":"5","key":"2878_CR1","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/2047487319870344","volume":"27","author":"A Aimo","year":"2020","unstructured":"Aimo A, Castiglione V, Borrelli C, Saccaro LF, Franzini M, Masi S, et al. Oxidative stress and inflammation in the evolution of heart failure: from pathophysiology to therapeutic strategies. Eur J Prev Cardiol. 2020;27(5):494\u2013510.","journal-title":"Eur J Prev Cardiol"},{"key":"2878_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10741-006-9196-2","volume":"11","author":"A Yndestad","year":"2006","unstructured":"Yndestad A, Dam\u00e5s JK, Oie E, Ueland T, Gullestad L, Aukrust P. Systemic inflammation in heart failure \u2013 the whys and wherefores. Heart Fail Rev. 2006;11:83\u201392.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"2878_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10741-016-9533-z","volume":"21","author":"A Briasoulis","year":"2016","unstructured":"Briasoulis A, Androulakis E, Christophides T, Tousoulis D. The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure. Heart Fail Rev. 2016;21(1):169\u201376.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"2878_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/heartasia-2013-010484","volume":"6","author":"M Liu","year":"2014","unstructured":"Liu M, Chen J, Huang D, Ke J, Wu W. A meta-analysis of proinflammatory cytokines in chronic heart failure. Heart Asia. 2014;6(1):130\u20136.","journal-title":"Heart Asia"},{"issue":"1","key":"2878_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/cvr\/cvz198","volume":"116","author":"P Pellicori","year":"2020","unstructured":"Pellicori P, Zhang J, Cuthbert J, Urbinati A, Shah P, Kazmi S, et al. High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death. Cardiovasc Res. 2020;116(1):91\u2013100.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"2878_CR6","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.110935","volume":"140","author":"M Petretta","year":"2000","unstructured":"Petretta M, Condorelli GL, Spinelli L, Scopacasa F, de Caterina M, Leosco D, et al. Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure. Am Heart J. 2000;140(6):E28.","journal-title":"Am Heart J"},{"issue":"4","key":"2878_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/eurheartj\/ehr457","volume":"33","author":"R Pfister","year":"2012","unstructured":"Pfister R, Sharp SJ, Luben R, Wareham NJ, Khaw KT. Differential white blood cell count and incident heart failure in men and women in the EPIC-Norfolk study. Eur Heart J. 2012;33(4):523\u201330.","journal-title":"Eur Heart J"},{"issue":"4","key":"2878_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1939-1676.2004.tb02575.x","volume":"18","author":"AE Farabaugh","year":"2004","unstructured":"Farabaugh AE, Freeman LM, Rush JE, George KL. Lymphocyte subpopulations and hematologic variables in dogs with congestive heart failure. J Vet Intern Med. 2004;18(4):505\u20139.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"2878_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1939-1676.2012.00923.x","volume":"26","author":"SM Cunningham","year":"2012","unstructured":"Cunningham SM, Rush JE, Freeman LM. Systemic inflammation and endothelial dysfunction in dogs with congestive heart failure. J Vet Intern Med. 2012;26(3):547\u201357.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"2878_CR10","first-page":"836","volume":"4","author":"BR Deepti","year":"2015","unstructured":"Deepti BR, Yathiraj S. Hematological and biochemical variables in congestive heart failure in dogs. Int J Sci Environ Technol. 2015;4(3):836\u201340.","journal-title":"Int J Sci Environ Technol"},{"key":"2878_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tvjl.2015.12.006","volume":"209","author":"MJ Reimann","year":"2016","unstructured":"Reimann MJ, Ljungvall I, Hillstr\u00f6m A, Moller JE, Hagman R, Falk T, et al. Increased serum C\u2013reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease. Vet J. 2016;209:113\u20138.","journal-title":"Vet J"},{"issue":"1","key":"2878_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13028-018-0372-x","volume":"60","author":"A Domanjko Petri\u010d","year":"2018","unstructured":"Domanjko Petri\u010d A, Lukman T, Verk B, Nemec SA. Systemic inflammation in dogs with advanced-stage heart failure. Acta Vet Scand. 2018;60(1):20.","journal-title":"Acta Vet Scand"},{"issue":"6","key":"2878_CR13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/jsap.12809","volume":"59","author":"J Hamilton-Elliot","year":"2018","unstructured":"Hamilton-Elliot J, Ambrose E, Christley R, Dukes-McEwan J. White blood cell differentials in dogs with congestive heart failure (CHF) in comparison to those in dogs without cardiac disease. J Small Anim Pract. 2018;59(6):364\u201372.","journal-title":"J Small Anim Pract"},{"issue":"1","key":"2878_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.tvjl.2011.05.009","volume":"192","author":"NE Zois","year":"2012","unstructured":"Zois NE, Moesgaard SG, Kjelgaard-Hansen M, Rasmussen SE, Falk T, Fossing C, et al. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve diesease. Vet J. 2012;192(1):106\u201311.","journal-title":"Vet J"},{"issue":"1","key":"2878_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12917-020-02650-7","volume":"16","author":"CP Rubio","year":"2020","unstructured":"Rubio CP, Saril A, Kocaturk M, Tanaka R, Koch J, Ceron JJ, et al. Changes of inflammatory and oxidative stress biomarkers in dogs with different stages of heart failure. BMC Vet Res. 2020;16(1):433. https:\/\/doi.org\/10.1186\/s12917-020-02650-7.","journal-title":"BMC Vet Res"},{"issue":"10A","key":"2878_CR16","doi-asserted-by":"publisher","first-page":"58D","DOI":"10.1016\/j.amjcard.2008.02.010","volume":"101","author":"FJ Pashkow","year":"2008","unstructured":"Pashkow FJ, Watumull DG, Campbell CL. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol. 2008;101(10A):58D\u201368D.","journal-title":"Am J Cardiol"},{"issue":"6","key":"2878_CR17","doi-asserted-by":"publisher","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","volume":"301","author":"H Tsutsui","year":"2011","unstructured":"Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol. 2011;301(6):H2181\u201390.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"2878_CR18","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/eurheartj\/14.11.1493","volume":"14","author":"J McMurray","year":"1993","unstructured":"McMurray J, Chopra M, Abdullah I, Smith WE, Dargie HJ. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J. 1993;14(11):1493\u20138.","journal-title":"Eur Heart J"},{"issue":"6","key":"2878_CR19","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/S0735-1097(98)00101-6","volume":"31","author":"M Keith","year":"1998","unstructured":"Keith M, Geranmayegan A, Sole MJ, et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol. 1998;31(6):1352\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2878_CR20","first-page":"145","volume":"12","author":"W Szczurek","year":"2015","unstructured":"Szczurek W, Szygula-Jurkiewicz B. Oxidative stress and inflammatory markers \u2013 the future of heart failure diagnostics? Kardiochir Torakochirurgia Pol. 2015;12(5):145\u20139.","journal-title":"Kardiochir Torakochirurgia Pol"},{"issue":"5","key":"2878_CR21","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2460\/javma.1999.215.05.644","volume":"215","author":"LM Freeman","year":"1999","unstructured":"Freeman LM, Brown DJ, Rush JE. Assessment of degree of oxidative stress and antioxidant concentrations in dogs with idiopathic dilated cardiomyopathy. J Am Vet Med Assoc. 1999;215(5):644\u20136.","journal-title":"J Am Vet Med Assoc"},{"issue":"4","key":"2878_CR22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1939-1676.2005.tb02724.x","volume":"19","author":"LM Freeman","year":"2005","unstructured":"Freeman LM, Rush JE, Milbury PE, Blumberg JB. Antioxidant status and biomarkers of oxidative stress in dogs with congestive heart failure. J Vet Intern Med. 2005;19(4):537\u201341.","journal-title":"J Vet Intern Med"},{"issue":"4","key":"2878_CR23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1042\/CS20050317","volume":"110","author":"M White","year":"2006","unstructured":"White M, Ducharme A, Ibrahim R, Whittom L, Lavoie J, Guertin MC. Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. Clin Sci (Lond). 2006;110(4):483\u20139.","journal-title":"Clin Sci (Lond)"},{"key":"2878_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.vph.2015.03.005","volume":"71","author":"HN Siti","year":"2015","unstructured":"Siti HN, Kamisaha Y, Kamisaha J. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Vasc Pharmacol. 2015;71:40\u201356.","journal-title":"Vasc Pharmacol"},{"issue":"8","key":"2878_CR25","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/S0735-1097(01)01299-2","volume":"37","author":"T Tsutamoto","year":"2001","unstructured":"Tsutamoto T, Wada A, Matsumoto T, Maeda K, Mabuchi N, Hayashi M, et al. Relationship between tumor necrosis factor\u2013alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy. J Am Coll Cardiol. 2001;37(8):2086\u201392.","journal-title":"J Am Coll Cardiol"},{"key":"2878_CR26","doi-asserted-by":"publisher","first-page":"514","DOI":"10.4061\/2011\/514623","volume":"2011","author":"FJ Pashkow","year":"2011","unstructured":"Pashkow FJ. Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and\/or prevention? Int J Inflamm. 2011;2011:514\u2013623.","journal-title":"Int J Inflamm"},{"key":"2878_CR27","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.rvsc.2011.10.020","volume":"93","author":"S Fonfara","year":"2012","unstructured":"Fonfara S, Tew SR, Cripps P, Dukes-McEwan J, Clegg PD. Increased blood mRNA expression of inflammatory and anti-fibrotic markers in dogs with congestive heart failure. Res Vet Sci. 2012;93:879\u201385.","journal-title":"Res Vet Sci"},{"issue":"3","key":"2878_CR28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2460\/ajvr.74.3.408","volume":"74","author":"S Fonfara","year":"2013","unstructured":"Fonfara S, Hetzel U, Tew SR, Cripps P, Dukes-McEwan J, Clegg PD. Myocardial cytokine expression in dogs with systemic and naturally occurring cardiac diseases. Am J Vet Res. 2013;74(3):408\u201316.","journal-title":"Am J Vet Res"},{"key":"2878_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1939-1676.1994.tb03249.x","volume":"8","author":"LM Freeman","year":"1994","unstructured":"Freeman LM, Rush JE, Brown DJ, Roubenoff R. Elevated concentrations of tumor necrosis factor in dogs with congestive heart failure. J Vet Intern Med. 1994;8:146.","journal-title":"J Vet Intern Med"},{"issue":"6","key":"2878_CR30","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1939-1676.1998.tb02148.x","volume":"12","author":"LM Freeman","year":"1998","unstructured":"Freeman LM, Rush JE, Kehayias JJ, Ross JN Jr, Meydani SN, Brown DJ, et al. Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure. J Vet Intern Med. 1998;12(6):440\u20138.","journal-title":"J Vet Intern Med"},{"key":"2878_CR31","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1111\/jvim.14570","volume":"30","author":"HS Kim","year":"2016","unstructured":"Kim HS, Kang JH, Jeung EB, Yang MP. Serum concentration of leptin and adiponectin in dogs with myxomatous mitral valve disease. J Vet Intern Med. 2016;30:1589\u2013600.","journal-title":"J Vet Intern Med"},{"issue":"1","key":"2878_CR32","first-page":"e1","volume":"1","author":"O Chen","year":"2014","unstructured":"Chen O, Patel J, Mohamed E, Greene M, Moskovits N, Shani J. The Immunoregulatory role of cytokines in congestive heart failure. Interdiscip J Microinflam. 2014;1(1):e1\u20136.","journal-title":"Interdiscip J Microinflam"},{"issue":"3","key":"2878_CR33","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1939-1676.2006.tb02908.x","volume":"20","author":"JE Rush","year":"2006","unstructured":"Rush JE, Lee ND, Freeman LM, Brewer B. C-reactive protein concentration in dogs with chronic valvular disease. J Vet Intern Med. 2006;20(3):635\u20139.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"2878_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1161\/CIRCHEARTFAILURE.108.827071","volume":"2","author":"G Engstr\u00f6m","year":"2009","unstructured":"Engstr\u00f6m G, Melander O, Hedblad B. Leukocyte count and incidence of hospitalizations due to heart failure. Circ Heart Fail. 2009;2(3):217\u201322.","journal-title":"Circ Heart Fail"},{"issue":"2","key":"2878_CR35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5603\/KP.a2016.0147","volume":"75","author":"M Ostrowska","year":"2017","unstructured":"Ostrowska M, Ostrowski A, \u0141uczak M, Jaguszewski M, Adamski P, Bellwon J, et al. Basic laboratory parameters as predictors of in-hospital death in patients with acute decompensated heart failure: data from a large single-Centre cohort. Kardiol Pol. 2017;75(2):157\u201363.","journal-title":"Kardiol Pol"},{"issue":"4","key":"2878_CR36","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11897-017-0337-9","volume":"14","author":"S Van Linthout","year":"2017","unstructured":"Van Linthout S, Tsch\u00f6pe C. Inflammation \u2013 cause or consequence of heart failure or both? Curr Heart Fail Rep. 2017;14(4):251\u201365.","journal-title":"Curr Heart Fail Rep"},{"issue":"12","key":"2878_CR37","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/ncpcardio1364","volume":"5","author":"AJ Ijsselmuiden","year":"2008","unstructured":"Ijsselmuiden AJ, Musters RJ, de Ruiter G, van Heerebeek L, Alderse-Baas F, van Schilfgaarde M, et al. Circulating white blood cells and platelets amplify oxidative stress in heart failure. Nat Clin Pract Cardiovasc Med. 2008;5(12):811\u201320.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"6","key":"2878_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1527-5299.2001.00261.x","volume":"7","author":"A Serdar","year":"2001","unstructured":"Serdar A, Yesilbursa D, Serdar Z, Dirican M, Turel B, Cordan J. Relation of functional capacity with the oxidative stress and antioxidants in chronic heart failure. Congest Heart Fail. 2001;7(6):309\u201311.","journal-title":"Congest Heart Fail"},{"issue":"4","key":"2878_CR39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cardfail.2003.11.004","volume":"10","author":"MC Polidori","year":"2004","unstructured":"Polidori MC, Pratic\u00f3 D, Savino K, Rokach J, Stahl W, Mecocci P. Increased F2 isoprostane plasma levels in patients with congestive heart failure are correlated with antioxidant status and disease severity. J Card Fail. 2004;10(4):334\u20138.","journal-title":"J Card Fail"},{"issue":"3","key":"2878_CR40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1939-1676.2003.tb02454.x","volume":"17","author":"AM De Laforcade","year":"2003","unstructured":"De Laforcade AM, Freeman LM, Rush JE. Serum nitrate and nitrite in dogs with spontaneous cardiac disease. J Vet Intern Med. 2003;17(3):315\u20138.","journal-title":"J Vet Intern Med"},{"issue":"7","key":"2878_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1023\/A:1005929801735","volume":"21","author":"P Vajdovich","year":"1997","unstructured":"Vajdovich P, Gaal T, Szilagyi A, Harnos A. Changes in some red blood cell and clinical laboratory parameters in young and old beagle dogs. Vet Res Commun. 1997;21(7):463\u201370.","journal-title":"Vet Res Commun"},{"key":"2878_CR42","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1093\/jn\/136.7.1844","volume":"136","author":"HD Stowe","year":"2006","unstructured":"Stowe HD, Lawler DF, Kealy RD. Antioxidant status of pair-fed Labrador retrievers is affected by diet restriction and aging. J Nutr. 2006;136:1844\u20138.","journal-title":"J Nutr"},{"issue":"4","key":"2878_CR43","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1515\/acve-2016-0046","volume":"66","author":"K Tomsi\u010d","year":"2016","unstructured":"Tomsi\u010d K, Seli\u0161kar A, Lukanc B, Nemec SA. Plasma total antioxidant capacity and activities of blood glutathione peroxidase and superoxide dismutase determined in healthy dogs by using commercially available kits. Acta Veterinaria. 2016;66(4):534\u201348.","journal-title":"Acta Veterinaria"},{"issue":"1","key":"2878_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/vcp.12459","volume":"46","author":"LB Radakovich","year":"2017","unstructured":"Radakovich LB, Pannone SC, Truelove MP, Olver CS, Santangelo KS. Hematology and biochemistry of aging \u2013 evidence of \u2018anemia of the elderly\u2019 in old dogs. Vet Clin Pathol. 2017;46(1):34\u201346.","journal-title":"Vet Clin Pathol"},{"issue":"2","key":"2878_CR45","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/jvim.14647","volume":"31","author":"MJ Reimann","year":"2017","unstructured":"Reimann MJ, Haggstrom J, Moller JE, Lykkesfeldt J, Falk T, Olsen LH. Markers of oxidative stress in dogs with myxomatous mitral valve disease are influenced by sex, neuter status, and serum cholesterol concentration. J Vet Intern Med. 2017;31(2):295\u2013302.","journal-title":"J Vet Intern Med"},{"issue":"5","key":"2878_CR46","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/1040638717711995","volume":"29","author":"B Verk","year":"2017","unstructured":"Verk B, Nemec Svete A, Salobir J, Rezar V, Domanjko PA. Markers of oxidative stress in dogs with heart failure. J Vet Diagn Investig. 2017;29(5):636\u201344.","journal-title":"J Vet Diagn Investig"},{"issue":"2","key":"2878_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1760-2734(06)70047-9","volume":"5","author":"J Dukes-McEwan","year":"2003","unstructured":"Dukes-McEwan J, Borgarelli M, Tidholm A, Vollmar AC, Haggstrom J. Proposed guidelines for the diagnosis of canine idiopathic dilated cardiomyopathy. J Vet Cardiol. 2003;5(2):7\u201319.","journal-title":"J Vet Cardiol"},{"key":"2878_CR48","first-page":"158","volume":"70","author":"DE Paglia","year":"1967","unstructured":"Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158\u201369.","journal-title":"J Lab Clin Med"},{"issue":"6","key":"2878_CR49","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/ps\/86.6.1155","volume":"86","author":"V Rezar","year":"2010","unstructured":"Rezar V, Franki\u010d T, Levart A, Salobir J. Dose-dependent effects of F2-toxin on performance, lipid peroxidation, and genotoxicity in broiler chickems. Poult Sci. 2010;86(6):1155\u201360.","journal-title":"Poult Sci"},{"issue":"1","key":"2878_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/1040638714562826","volume":"27","author":"RJ Cahill","year":"2015","unstructured":"Cahill RJ, Pigeon K. Strong\u2013Townsend MI, Drexel JP, Clark GH, Buch JS. Analytical validation of a second-generation immunoassay for the quantification of N-terminal pro-B-type natriuretic peptide in canine blood. J Vet Diagn Investig. 2015;27(1):61\u20137.","journal-title":"J Vet Diagn Investig"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-021-02878-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-021-02878-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-021-02878-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T08:08:15Z","timestamp":1724918895000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-021-02878-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2878"],"URL":"https:\/\/doi.org\/10.1186\/s12917-021-02878-x","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,26]]},"assertion":[{"value":"5 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that the study was carried out in compliance with the ARRIVE guidelines.The Ethical Committee of the Ministry of Agriculture, Forestry and Food, Veterinary Administration of the Republic of Slovenia approved all procedures.All procedures complied with the relevant Slovenian (Animal Protection Act, Official Gazette of the Republic of Slovenia, No. 43\/2007) regulations.All owners signed an informed consent form before enrolling the dogs in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}